FCER2 and B-cell chronic lymphocytic leukemia: Chronic lymphocytic leukemia (CLL) is characterized by monoclonal proliferation of CD5 positive B cells, and this phenotype also has coexpression of CD19, CD5, and CD23 markers [1, 2].